SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of the earliest event reported):February 1, 2006
NEUROCRINE BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
0-22705
|
|
33-0525145 |
(State or other
|
|
(Commission File
|
|
(IRS Employer Identification No.) |
jurisdiction of
|
|
Number) |
|
|
incorporation or |
|
|
|
|
organization) |
|
|
|
|
|
|
|
12790 El Camino Real
|
|
92130 |
(Address of principal executive offices)
|
|
(Zip Code) |
Registrants telephone number, including area code: (858) 617-7600
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))
TABLE OF CONTENTS
Item 1.02 Termination of a Material Definitive Agreement
On February 1, 2006 Robert Little, former Senior Vice President
Commercial Operations resigned his position with Neurocrine Biosciences, Inc. (the Company) to pursue
other interests. Mr. Little had an employment agreement dated June 16, 2003 with the Registrant that provided an annual
base salary and eligibility for an annual bonus and equity awards as
determined by the Board of Directors. The employment agreement
terminated upon Mr. Littles resignation. However, in connection with his resignation,
Mr. Little and the Company entered into a Consulting Agreement dated February 1, 2006 pursuant to which Mr. Little
has agreed to provide consulting services supporting the Companys commercial operations through the end of 2006.